Prevalence of DAO (diamino Oxidase) Deficiency in Newborns

NCT06710366 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-11-29

No results posted yet for this study

Summary

Observational study to estimate the prevalence of genetic DAO deficiency in the population.

Conditions

  • DAO Genetic Variants

Sponsors & Collaborators

  • Grupo Hospitalario Quironsalud-Catalunya

    collaborator UNKNOWN
  • Hospital Universitari General de Catalunya

    collaborator OTHER
  • Quironsalud

    collaborator OTHER
  • AB Biotek

    lead INDUSTRY

Eligibility

Min Age
0 Days
Max Age
3 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-28
Primary Completion
2024-06-21
Completion
2024-06-26

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06710366 on ClinicalTrials.gov